IntelGenx Technologies Corp. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 25 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-11-28: Reporting owner Boudreau Bernard; Form 4; Security (Option) right to buy; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-09-21: Reporting owner Matzen Dana; Form 3; Security Options, right to buy (Common stock 0.00001 p.v.); Transaction Holding.
- 2016-09-21: Reporting owner Matzen Dana; Form 3; Security Options, right to buy (Common stock 0.00001 p.v.); Transaction Holding.
- 2016-09-21: Reporting owner Matzen Dana; Form 3; Security Options, right to buy (Common stock 0.00001 p.v.); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-11-28 | Boudreau Bernard Director | 4 | (Option) right to buy Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 160,000 owned after | $0.54 exercise price | 2016-11-30 | |
| 2016-09-21 holding as of filing | Matzen Dana Officer (VP Business+Corp. Development) | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-09-21 holding as of filing | Matzen Dana Officer (VP Business+Corp. Development) | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-09-21 holding as of filing | Matzen Dana Officer (VP Business+Corp. Development) | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-09-21 holding as of filing | Matzen Dana Officer (VP Business+Corp. Development) | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-09-21 holding as of filing | Nawacki Mark Director | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-09-21 holding as of filing | Nawacki Mark Director | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-09-21 holding as of filing | Nawacki Mark Director | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-09-21 holding as of filing | Nawacki Mark Director | 3 | Options, right to buy (Common stock 0.00001 p.v.) Derivative · Direct | Holding | $0.73 exercise price | 2016-09-21 | ||
| 2016-01-28 holding as of filing | Paiement Nadine Officer (VP Research + Development) | 3 | Options, right to buy (Par Value 0.00001) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Paiement Nadine Officer (VP Research + Development) | 3 | Options, right to buy (Par Value 0.00001) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Paiement Nadine Officer (VP Research + Development) | 3 | Options, right to buy (Par Value 0.00001) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Paiement Nadine Officer (VP Research + Development) | 3 | Options, right to buy (Par Value 0.00001) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Paiement Nadine Officer (VP Research + Development) | 3 | Options, right to buy Derivative · Direct | Holding | $0.52 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Paiement Nadine Officer (VP Research + Development) | 3 | Options, right to buy Derivative · Direct | Holding | $0.54 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Paiement Nadine Officer (VP Research + Development) | 3 | Options, right to buy Derivative · Direct | Holding | $0.51 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Bechard Robert J. Officer (VP Corporate Development) | 3 | Options, right to buy (common stock 0.00001 pv) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Bechard Robert J. Officer (VP Corporate Development) | 3 | Options, right to buy (common stock 0.00001 pv) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Bechard Robert J. Officer (VP Corporate Development) | 3 | Options, right to buy (common stock 0.00001 pv) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-28 holding as of filing | Bechard Robert J. Officer (VP Corporate Development) | 3 | Options, right to buy (common stock 0.00001 pv) Derivative · Direct | Holding | $0.41 exercise price | 2016-01-28 | ||
| 2016-01-19 | Boudreau Bernard Director | 4 | Options to buy (Par Value 0.00001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 200,000 owned after | $0.41 exercise price | 2016-01-22 | |
| 2016-01-19 | Mayr Clemens Director | 4 | Options Right to buy (Par 0.00001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 125,000 owned after | $0.41 exercise price | 2016-01-22 | |
| 2016-01-19 | Troup John Archibald Director | 4 | Options Right to buy (Par 0.00001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 125,000 owned after | $0.41 exercise price | 2016-01-22 | |
| 2016-01-19 | Melchers Bernd Josef Director | 4 | Options to buy (Par 0.00001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 125,000 owned after | $0.41 exercise price | 2016-01-22 | |
| 2016-01-19 | Marinucci John Director | 4 | Options Right to buy (par 0.00001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 100,000 owned after | $0.41 exercise price | 2016-01-22 |